Addition of erlotinib to cisplatin did not increase response PFS in SCCHN
Martins RG. J Clin Oncol. 2013;doi:10.1200/JCO.2012.46.3299.
Source: HemOncToday.com - Category: Cancer & Oncology Source Type: news
More News: Cancer & Oncology | Tarceva